Permira inks Japan's largest ever buyout

Permira will buy Arysta LifeScience from Olympus Capital for a firm value of $2.2 billion.

Europe's largest buyout fund has bid Ñ250 billion $2.2 billion to win Japanese agrochemicals company, Arysta LifeSciences, in a deal which yields private equity firm Olympus Capital a whopper return.

The price represents an equity value of Ñ100 billion, which will be entirely contributed by Permira. Sources close to the deal confirmed that Lehman Brothers provided the balance Ñ150 billion staple financing to the bidders, including both senior debt and mezzanine financing.

Arysta was formed in 2001 through a...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Click for more on: permira | arysta | olympus capital | david shen

Print Edition

FinanceAsia Print Edition